Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Trends in Cancer
|
October 20, 2023
Making normal hematopoiesis invisible to CAR T cells
Miriam Y Kim
Blood
|
May 25, 2023
CXCR4 to improve both T cell homing and function
Miriam Y Kim
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
May 24, 2019
Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry
Palak Sekhri, Miriam Y Kim, Gregory K Behbehani
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2025
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity
Rubina Thomas, Julie K Ritchey, John F DiPersio, et al.
Oncology
|
July 26, 2014
Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma
Miriam Y Kim, Richard Sposto, Abhisek Swaika, et al.
JCI Insight
|
August 23, 2021
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
Miriam Y Kim, Matthew L Cooper, Miriam T Jacobs, et al.
Blood
|
December 23, 2022
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells
Joseph C Rimando, Ezhilarasi Chendamarai, Michael P Rettig, et al.
Nature Communications
|
June 13, 2022
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
Miriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, et al.
Leukemia
|
October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies
Jingyu Xiang, Jessica M Devenport, Alun J Carter, et al.
Haematologica
|
March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
Francesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Trends in Cancer
|
October 20, 2023
Making normal hematopoiesis invisible to CAR T cells
Miriam Y Kim
Blood
|
May 25, 2023
CXCR4 to improve both T cell homing and function
Miriam Y Kim
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
May 24, 2019
Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry
Palak Sekhri, Miriam Y Kim, Gregory K Behbehani
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2025
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activity
Rubina Thomas, Julie K Ritchey, John F DiPersio, et al.
Oncology
|
July 26, 2014
Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma
Miriam Y Kim, Richard Sposto, Abhisek Swaika, et al.
JCI Insight
|
August 23, 2021
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
Miriam Y Kim, Matthew L Cooper, Miriam T Jacobs, et al.
Blood
|
December 23, 2022
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells
Joseph C Rimando, Ezhilarasi Chendamarai, Michael P Rettig, et al.
Nature Communications
|
June 13, 2022
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
Miriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, et al.
Leukemia
|
October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies
Jingyu Xiang, Jessica M Devenport, Alun J Carter, et al.
Haematologica
|
March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
Francesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Page
of 2